Skip to content
About EDC
About
Board Members
Our Impact
Client Application Form
Services
Client Stories
Collective Data
Alpha Trailers
Bazooka Farmstar
Perspectives Therapeutics
Pear Deck
Resources
FAQ
News
Blog
Partnerships
Contact
About EDC
About
Board Members
Our Impact
Client Application Form
Services
Client Stories
Collective Data
Alpha Trailers
Bazooka Farmstar
Perspectives Therapeutics
Pear Deck
Resources
FAQ
News
Blog
Partnerships
Contact
Search
October 10, 2022
Viewpoint Molecular Targeting Announces Transformational Merger
View Press Release
Prev
Previous
Coralville-Based Viewpoint Molecular Targeting™ Commences Patient Enrollment in Phase 1 Imaging Study for VMT01 Program for Metastatic Melanoma
Next
Viewpoint Molecular Targeting and Isoray, Inc. complete merger
Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
